Evaluation of the risk of occupational exposure to antineoplastic drugs in healthcare sector: part II – the application of the FMECA method to compare manual vs automated preparation

Dugheri, Stefano; Cappelli, Giovanni; Squillaci, Donato; Rapi, Ilaria; Fanfani, Niccolò; Dori, Fabrizio; Cecchi, Michele; Sordi, Viola; Ghiori, Andrea; Mucci, Nicola

doi:10.2478/aiht-2024-75-3803

References

1. Institute for Safe Medication Practices (ISIMP). ISMP list of high-alert medications in acute care settings [displayed 7 March 2024]. Available at https://www.ismp.org/sites/default/files/attachments/2018-08/highAlert2018-Acute-Final.pdf
Institute for Safe Medication Practices (ISIMP) ISMP list of high-alert medications in acute care settings [displayed 7 March 2024] Available at https://www.ismp.org/sites/default/files/attachments/2018-08/highAlert2018-Acute-Final.pdf

Back to article
Carrez L, Falaschi L, Cingria L, Sadeghipour F, Bouchoud L, Bonnabry P. [Organisation et sécurisation du circuit des chimiothérapies: Exemple de la pharmacie des Hôpitaux Universitaires de Genève, in French]. Pharmactuel 2014;47:119–24.
Search in Google Scholar Back to article
Palma E, Bufarini C. Robotized compounding of oncology drugs in a hospital pharmacy. Int J Pharm Compd 2014;18:358–64. PMID: 25577883
Search in Google Scholar Back to article
Hon C-Y, Teschke K, Chua P, Venners S, Nakashima L. Occupational exposure to antineoplastic drugs: identification of job categories potentially exposed throughout the hospital medication system. Saf Health Work 2011;2(3):273–81. doi: 10.5491/SHAW.2011.2.3.273
Open DOI Search in Google Scholar Back to article
Ndaw S, Remy A. Occupational exposure to antineoplastic drugs in twelve French health care setting: biological monitoring and surface contamination. Int J Environ Res Public Health 2023;20(6):4952. doi: 10.3390/ijerph20064952
Open DOI Search in Google Scholar Back to article
Mucci N, Dugheri S, Farioli A, Garzaro G, Rapisarda V, Campagna M, Bonari A, Arcangeli G. Occupational exposure to antineoplastic drugs in hospital environments: potential risk associated with contact with cyclophosphamide- and ifosfamide-contaminated surfaces. Med Pr 2020;71:519–29. doi: 10.13075/mp.5893.00931
Open DOI Search in Google Scholar Back to article
Dugheri S, Mucci N, Mini E, Cappelli G, Bucaletti E, Squillaci D, Trevisani L, Arcangeli G. An update on permeation of protective medical gloves by antineoplastic drugs. Sigurnost 2022;64:341–57. doi: 10.31306/s.64.4.2
Open DOI Search in Google Scholar Back to article
Korczowska E, Jankowiak-Gracz H, Crul M, Tuerk J, Arnold D, Meier K. Surface contamination with cytotoxic drugs in european hospital wards. Eur J Hosp Pharm 2020;27(Suppl 1):A41.
Search in Google Scholar Back to article
Falck K, Gröhn P, Sorsa M, Vainio H, Heinonen E, Holsti LR. Mutagenicity in urine of nurses handling cytostatic drugs. Lancet 1979;313:1250–1. doi: 10.1016/s0140-6736(79)91939-1
Open DOI Search in Google Scholar Back to article
10. Nurse24.it. Manipolazione farmaci antiblastici: Uno sguardo al futuro [Handling antineoplastic pharmaceuticals: a look at the future, in Italian] [displayed 20 August 2023]. Available at https://www.nurse24.it/infermiere/farmaci/antiblastici-manipolazione-rischi-infermiere.html
Nurse24.it Manipolazione farmaci antiblastici: Uno sguardo al futuro [Handling antineoplastic pharmaceuticals: a look at the future, in Italian] [displayed 20 August 2023] Available at https://www.nurse24.it/infermiere/farmaci/antiblastici-manipolazione-rischi-infermiere.html

Back to article
11. AboutPharma. Preparazione di farmaci antiblastici, quadro ancora frammentato in Italia: “serve fare rete” [Preparation of antineoplastic pharmaceuticals, still a fragmented picture in Italy: needs creating a net, in Italian] [displayed 20 August 2023]. Available at https://www.aboutpharma.com/business-e-mercato/preparazione-farmaciantiblastici-quadro-ancora-frammentato-italia-serve-rete/
AboutPharma Preparazione di farmaci antiblastici, quadro ancora frammentato in Italia: “serve fare rete” [Preparation of antineoplastic pharmaceuticals, still a fragmented picture in Italy: needs creating a net, in Italian] [displayed 20 August 2023]. Available at https://www.aboutpharma.com/business-e-mercato/preparazione-farmaciantiblastici-quadro-ancora-frammentato-italia-serve-rete/

Back to article
Adade CA, Benabbes M, Belahcen MJ, Rahali Y. Centralization impact and cost-saving study in a Moroccan hospital’s centralized unit of chemotherapy preparation. J Oncol Pharm Pract 2020;26:1630–6. doi: 10.1177/1078155220901336
Open DOI Search in Google Scholar Back to article
13. Notiziario Chimico Farmaceutico. [UFA: Unità Farmaci Antiblastici, in Italian] [displayed 20 August 2023]. Available at https://www.notiziariochimicofarmaceutico.it/2017/09/04/migliorare-la-gestionedelle-ufa/
Notiziario Chimico Farmaceutico [UFA: Unità Farmaci Antiblastici, in Italian] [displayed 20 August 2023]. Available at https://www.notiziariochimicofarmaceutico.it/2017/09/04/migliorare-la-gestionedelle-ufa/

Back to article
14. HTA Focus. Pills of Clinical Governance 2017;4(2):55–120 [displayed 20 August 2023]. Available at https://www.htafocus.it/pdfvol4-n2-2017
HTA Focus Pills of Clinical Governance 2017 4 2 55 120 [displayed 20 August 2023]. Available at https://www.htafocus.it/pdfvol4-n2-2017

Back to article
15. Farmacia Ospedaliera. [Rapporto tra numero di preparati allestiti al giorno, personale necessario e costo per preparato nelle UFA, in Italian] [displayed 20 August 2023]. Available at https://www.farmaciaospedaliera.it/rapporto-tra-numero-di-preparati-allestiti-algiorno-personale-necessario-e-costo-per-preparato-nelle-ufa/
Farmacia Ospedaliera [Rapporto tra numero di preparati allestiti al giorno, personale necessario e costo per preparato nelle UFA, in Italian] [displayed 20 August 2023]. Available at https://www.farmaciaospedaliera.it/rapporto-tra-numero-di-preparati-allestiti-algiorno-personale-necessario-e-costo-per-preparato-nelle-ufa/

Back to article
Cote DD, Torchia MG. Robotic system for i.v. antineoplastic drug preparation: description and preliminary evaluation under simulated conditions. Am J Hosp Pharm 1989;46:2286–93. PMID: 2589345
Search in Google Scholar Back to article
Fox BI, Felkey BG. Automated intravenous preparation: robots for the pharmacy. Hosp Pharm 2009;44:255–7. doi: 10.1310/hpj4403-255
Open DOI Search in Google Scholar Back to article
Schoening T, Artes A, Ehmann M, Mertens M, Ober M, Hoppe-Tichy T. Semiautomated aseptic preparation of patient-individual antineoplastic intravenous solutions: first experiences in a German hospital pharmacy. Eur J Hosp Pharm 2016;23:44–9. doi: 10.1136/ejhpharm-2015-000655
Open DOI Search in Google Scholar Back to article
Schierl R, Masini C, Groeneveld S, Fischer E, Böhlandt A, Rosini V, Paolucci D. Environmental contamination by cyclophosphamide preparation: Comparison of conventional manual production in biological safety cabinet and robot-assisted production by APOTECAchemo. J Oncol Pharm Pract 2014;22:37–45. doi: 10.1177/1078155214551316
Open DOI Search in Google Scholar Back to article
Carrez L, Martin V, Verrey A, Furrer P, Bouchoud L, Falaschi L, Bonnabry P. Qualification and performance evaluation of an automated system for compounding injectable cytotoxic drugs. Pharm Technol Hosp Pharm 2018;3:165–75. doi: 10.1515/pthp-2018-0012
Open DOI Search in Google Scholar Back to article
Yaniv AW, Knoer SJ. Implementation of an i.v.-compounding robot in a hospital-based cancer center pharmacy. Am J Health Syst Pharm 2013;70:2030–7. doi: 10.2146/ajhp120649
Open DOI Search in Google Scholar Back to article
Masini C, Nanni O, Antaridi S, Gallegati D, Marri M, Paolucci D, Minguzzi M, Altini M. Automated preparation of chemotherapy: quality improvement and economic sustainability. Am J Health Syst Pharm 2014;71:579–85. doi: 10.2146/ajhp130489
Open DOI Search in Google Scholar Back to article
Nurgat Z, Faris D, Mominah M, Vibar A, Al-Jazairi A, Ewing S, Ashour M, Qaisi SK, Balhareth S, Al-Jedai A. A three-year study of a first-generation chemotherapy-compounding robot. Am J Health Syst Pharm 2015;72:1036–45. doi: 10.2146/ajhp140256
Open DOI Search in Google Scholar Back to article
24. Foglia E, Asperti F, Bellavia D, Schettini F, Cecchi A, Morassutto C. Unità Farmaci Antitumorali: modelli organizzativi e logistici a confronto. Uno studio condotto in Friuli-Venezia Giulia ha analizzato diversi scenari per definire il setting organizzativo e logistico maggiormente efficiente per la preparazione di agenti chemioterapici [Antitumour Drug Union: facing organisational and logistical models, in Italian] [displayed 20 August 2023]. Available at https://trendsanita.it/unita-farmaci-antitumorali-organizzazione-logistica/
FogliaE AspertiF BellaviaD SchettiniF CecchiA MorassuttoC Unità Farmaci Antitumorali: modelli organizzativi e logistici a confronto. Uno studio condotto in Friuli-Venezia Giulia ha analizzato diversi scenari per definire il setting organizzativo e logistico maggiormente efficiente per la preparazione di agenti chemioterapici [Antitumour Drug Union: facing organisational and logistical models, in Italian] [displayed 20 August 2023]. Available at https://trendsanita.it/unita-farmaci-antitumorali-organizzazione-logistica/

Back to article
American Society of Health-System Pharmacists. ASHP guidelines on handling hazardous drugs. Am J Health Syst Pharm 2006;63:1172–93.
Search in Google Scholar Back to article
International Society of Oncology Pharmacy Practicioners Standards Committee. ISOPP standards of practice. Safe handling of cytotoxics. J Oncol Pharm Pract 2007;13(Suppl):1–81. doi: 10.1177/1078155207082350
Open DOI Search in Google Scholar Back to article
27. European Agency for Safety and Health at Work. Guidance for the safe management of hazardous medicinal products at work [displayed 20 August 2023]. Available at https://osha.europa.eu/en/publications/guidance-safe-management-hazardous-medicinal-products-work
European Agency for Safety and Health at Work Guidance for the safe management of hazardous medicinal products at work [displayed 20 August 2023]. Available at https://osha.europa.eu/en/publications/guidance-safe-management-hazardous-medicinal-products-work

Back to article
Yeh TM, Chen LY. Fuzzy-based risk priority number in FMEA for semiconductor wafer processes. Int J Prod Res 2014;52:539–49. doi: 10.1080/00207543.2013.837984
Open DOI Search in Google Scholar Back to article
Jiang Y, Jiang H, Ding S, Liu Q. Application of failure mode and effects analysis in a clinical chemistry laboratory. Clin Chim Acta Int J Clin Chem 2015;448:80–5. doi: 10.1016/j.cca.2015.06.016
Open DOI Search in Google Scholar Back to article
Lago P, Bizzarri G, Scalzotto F, Parpaiola A, Amigoni A, Putoto G, Perilongo G. Use of FMEA analysis to reduce risk of errors in prescribing and administering drugs in paediatric wards: a quality improvement report. BMJ Open 2012;2:e001249. doi:10.1136/bmjopen-2012-001249
Open DOI Search in Google Scholar Back to article
Cherif Chefchaouni A, Boudina Y, Chennaq M, Belahcen MJ, Rahali Y. Contribution of an anticancer drug compounding robot in reducing the risks of manual preparation in a hospital pharmacy unit specialized in oncology. J Oncol Pharm Pract 2023;29:1334–42. doi: 10.1177/10781552221118846
Open DOI Search in Google Scholar Back to article
Bhirich N, Chefchaouni AC, Medkouri SE, Shytry O, Belahcen MJ, Rahali Y. Risk assessment of personnel exposure in a central cytotoxic preparation unit using the FMECA method. J Oncol Pharm Pract 2023;29:1884–92. doi: 10.1177/10781552231153625
Open DOI Search in Google Scholar Back to article
Zribi K, Minh Mai Le L, Rajkumar A, Aboudagga H, Frikha M, Dietrich A, Zribi E, Safta F, Caudron E. Antineoplastic drug handling: higher risk for healthcare workers in Tunisia than in France? Biomed Environ Sci 2020;33:803–6. doi: 10.3967/bes2020.108
Open DOI Search in Google Scholar Back to article
Dugheri S, Squillaci D, Cappelli G, Saccomando V, Fanfani N, Ceccarelli J, Mucci N, Arcangeli G. Evaluation of the risk of occupational exposure to antineoplastic drugs in healthcare sector: part I – medical gloves. Arh Hig Rada Toksikol 2023;74:187–97. doi: 10.2478/aiht-2023-74-3734
Open DOI Search in Google Scholar Back to article
Gilpin WR, Powitz WR. NSF International NSF 49-2019 Informative Annex 1 (formerly Annex E) Biosafety cabinet selection, installation, use, lifespan and decommissioning [technical report 2020 NSF NSF/ANSI 49-2019]. doi: 10.13140/RG.2.2.31444.96645
Open DOI Search in Google Scholar Back to article
36. European Commission (EC). The rules governing medical products in the European Union volume 4 EU guidelines for good manufacturing practice for medical products for human and veterinary use [displayed 7 March 2024]. Available at: https://health.ec.europa.eu/document/download/e05af55b-38e9-42bf-8495-194bbf0b9262_en?filename=20220825_gmp-an1_en_0.pdf
European Commission (EC) The rules governing medical products in the European Union volume 4 EU guidelines for good manufacturing practice for medical products for human and veterinary use [displayed 7 March 2024] Available at: https://health.ec.europa.eu/document/download/e05af55b-38e9-42bf-8495-194bbf0b9262_en?filename=20220825_gmp-an1_en_0.pdf

Back to article
Heloury J, Bougeon G, Deljehier T, Jourand A, Berroneau A, Crauste-Manciet S. Automation of aseptic sterile preparation: risk analysis and productivity comparison with manual process. Pharm Technol Hosp Pharm 2019;4:15–28. doi: 10.1515/pthp-2019-0001
Open DOI Search in Google Scholar Back to article
Spivey S, Connor TH. Determining sources of workplace contamination with antineoplastic drugs and comparing conventional IV drug preparation with a closed system. Hosp Pharm 2003;38:135–9. doi: 10.1177/001857870303800
Open DOI Search in Google Scholar Back to article
Fleury-Souverain S, Nussbaumer S, Mattiuzzo M, Bonnabry P. Determination of the external contamination and cross-contamination by cytotoxic drugs on the surfaces of vials available on the Swiss market. J Oncol Pharm Pract 2013;20:100–11. doi: 10.1177/1078155213482683
Open DOI Search in Google Scholar Back to article
Silva LSE, Machado CDSB, Linden R, Antunes MV, da Silva LC, Wayhs CAY, Capp E, Ness SLR. Residual contamination in antineoplastic drug packaging. J Oncol Pharm Pract 2023;29:1862–7. doi: 10.1177/10781552231151693
Open DOI Search in Google Scholar Back to article
Hilliquin D, Tanguay C, Bussières JF. External contamination of commercial containers by antineoplastic agents: a literature review. Eur J Hosp Pharm 2020;27:313–4. doi: 10.1136/ejhpharm-2018-001705
Open DOI Search in Google Scholar Back to article
Gilbert RE, Kozak MC, Dobish RB, Bourrier VC, Koke PM, Kukreti V, Logan HA, Easty AC, Trbovich PL. Intravenous chemotherapy compounding errors in a follow-up pan-Canadian observational study. J Oncol Pract 2018;14(5):e295-e303. doi: 10.1200/JOP.17.00007
Open DOI Search in Google Scholar Back to article
Cotteret C, Secretan PH, Gilles-Afchain L, Rousseau J, Vidal F, Salguero-Hernandez G, Batista J, Valverde V, Guitton J, Cisternino S, Schlatter J. External contamination of antineoplastic drug vials: an occupational risk to consider. Eur J Hosp Pharm 2022;29:284–6. doi: 10.1136/ejhpharm-2020-002440
Open DOI Search in Google Scholar Back to article
Dugheri S, Mucci N, Bucaletti E, Squillaci D, Cappelli G, Trevisani L, Bonari A, Cecchi M, Mini E, Ghiori A, Tognoni D, Berti N, Alderighi F, Li Vigni N, Orlandi I, Arcangeli G. Monitoring surface contamination for thirty antineoplastic drugs: a new proposal for surface exposure levels (SELs). Med Pr 2022;73:383–96. doi: 10.13075/mp.5893.01288
Open DOI Search in Google Scholar Back to article
45. Shaikh H, Murhammer J, Sorenson S, Cleppe J, Amelon E, Lam F. Formulation options for cyclophosphamide. Oncology Safety 2022 [displayed 10 September 2023]. Available at https://www.pppmag.com/article/2881
ShaikhH MurhammerJ SorensonS CleppeJ AmelonE LamF Formulation options for cyclophosphamide Oncology Safety 2022 [displayed 10 September 2023]. Available at https://www.pppmag.com/article/2881

Back to article
46. US 2022/0296617 A1. Stable liquid formulations of cyclophosphamide and processed to prepare the same, 2022 [displayed 25 September 2023]. Available at https://patents.google.com/patent/US20220296617A1/en
US 2022/0296617 A1 Stable liquid formulations of cyclophosphamide and processed to prepare the same 2022 [displayed 25 September 2023]. Available at https://patents.google.com/patent/US20220296617A1/en

Back to article
Liston DR, Davis M. Clinically relevant concentrations of anticancer drugs: a guide for nonclinical studies. Clin Cancer Res 2017;23:3489–98. doi: 10.1158/1078-0432.CCR-16-3083
Open DOI Search in Google Scholar Back to article

Evaluation of the risk of occupational exposure to antineoplastic drugs in healthcare sector: part II – the application of the FMECA method to compare manual vs automated preparation

References

Paradigm

My account